Navigation Links
Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research

A survey of U.S. adults has found that a majority believe that HIV vaccines are the best hope for controlling the global AIDS epidemic and are confident such vaccines can be made. But while most of those surveyed felt it personally important to help support HIV vaccine research, a majority expressed reluctance to support a friend or family member’s participation in an HIV vaccine clinical trial.

These were among the conflicting findings of a telephone survey of more than 3,500 adults to assess attitudes, knowledge and awareness of HIV vaccine research in the United States. The survey, conducted by members of the HIV Vaccine Communications Campaign of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, points to the ongoing challenges HIV vaccine researchers face. A paper on the survey results is available online now and will be published in an upcoming print issue of the Journal of Acquired Immune Deficiency Syndromes.

“Tens of thousands of volunteers are required for the more than 30 HIV vaccine clinical trials currently planned or under way,?says NIAID director Anthony S. Fauci, M.D. “It is essential that current and future trials involve volunteers from diverse communities to enable us to find a vaccine that works for all populations.?/p>

“It is clear that we have a lot of work to do in explaining HIV vaccine research,?adds paper co-author Matthew Murguía, director of the Office of Program Operations and Scientific Information in the NIAID Division of AIDS. “We must develop strong partnerships with communities highly impacted by HIV/AIDS so individuals from these communities can make informed decisions about participating in HIV vaccine research.?/p>

The survey, conducted between December 2002 and February 2003, polled 2,008 U.S. adults aged 18 years of or older randomly selected from the general population. An additional 1,501 U.S. adults interviewed were randomly selected from each of three specific subpopulations highly affected by HIV ?African Americans, Hispanics and men who have sex with men.

The survey uncovered some unexpected attitudes and beliefs:

* 47 percent of African Americans, 26 percent of Hispanics, 13 percent of men who have sex with men, and 18 percent of the general population believe that an HIV vaccine already exists but is being kept a secret.
* Most subpopulation respondents ?78 percent of African Americans, 68 percent of men who have sex with men and 57 percent of Hispanics ?either do not know whether or incorrectly believe that the vaccines being tested can cause HIV infection. Only 24 percent of the general population responded comparably.
* Among men who have sex with men, 77 percent cited HIV/AIDS as the most urgent health problem. Only a small percentage of the other groups surveyed, however, agreed: 11 percent of Hispanics, 15 percent of the general population and 22 percent of African Americans.
* In general, women had less knowledge and awareness than men about HIV vaccine research.
* High percentages of each group felt it was important to personally support HIV vaccine research: 89 percent of both Hispanics and of men who have sex with men, 86 percent of African Americans and 73 percent of the general population. Nonetheless, many were reluctant to express strong support for friends or family members volunteering for HIV vaccine trials. Only 29 percent of the general population and 35 percent of African Americans said they would be extremely or very supportive. Hispanics and men who have sex with men were more inclined to be supportive: 46 percent and 68 percent, respectively.

The NIAID team also assessed trust in the U.S. government’s ability to protect HIV vaccine trial volunteers. While about half of three groups ?men who have sex with men (50 percent), African Americans (55 percent) and the general population (57 percent) ?said they could t rust the government to protect HIV vaccine trial volunteers, the rate of trust among Hispanics was significantly higher at 78 percent.

Based on interviews, focus groups and media analysis, NIAID team members first developed five key messages on vaccine research. They then designed the survey to determine whether these key messages were the most important ones for the HIV Vaccine Communications Campaign to address. These key messages were:

* There is currently no vaccine to prevent HIV infection.
* Only HIV-negative individuals can volunteer for a preventive HIV vaccine trial.
* You cannot become infected with HIV from the vaccines being tested.
* All populations must be involved in HIV vaccine research.
* An HIV preventive vaccine, complemented by strong behavioral prevention programs and AIDS care and treatment, is the best way to end the epidemic.

The results of the survey, says Mr. Murguía, have helped identify which populations researchers need to target for better understanding of HIV vaccine research, as well as which messages need to be tailored to specific populations. The NIAID team will work to lower the barriers that inhibit potential volunteers from diverse populations from participating in HIV vaccine trials and to increase community support for those who volunteer for a trial.


'"/>

Source:NIH


Related biology news :

1. Survey finds silver contamination in North Pacific waters
2. Survey reveals women and doctors arent talking about HPV
3. An HIV Protein Plays a Surprising Role in Gene Activation
4. Surprising findings reported about iron overload
5. Surprising symbiosis: Glassy-winged sharpshooter eats with friends
6. Towards precise classification of cancers based on robust gene functional expression profiles
7. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
8. Live Recombinant Adenovirus Vaccine Technique Explored
9. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
10. NIAID Initiates Trial of Experimental Avian Flu Vaccine
11. Study Models Impact Of Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)... 12, 2017 A new report by Allied Market Research, titled, ... biometric technology market is expected to generate revenue of $10.72 billion by 2022, with ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the ...
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock ... Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated to ... 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... Los Angeles, California (PRWEB) , ... January 11, ... ... collaborative approach to support fertility specialists with accurate and reliable preimplantation genetic screening ... and we have achieved excellent results,” says Ovation Fertility Genetics Scientific Director ...
(Date:1/11/2017)... NEW YORK , Jan. 11, 2017  Brian ... surgeon, and founder of Blue Horizon International (BHI), will ... in Davos from January 17-20, ... the global conference. The theme of this ... of the program,s 400 sessions will address strategies for ...
(Date:1/11/2017)... San Francisco, CA (PRWEB) , ... January 11, ... ... ongoing series of in-kind scientific grants to ground-breaking microbiome studies. Its most recent ... University School of Medicine, who will study the effect of long-term use of ...
Breaking Biology Technology: